At present, different supportive measures including corticosteroids, ACE-inhibitors, beta blockers and respiratory support are aiming to extend life expectancy of DMD patients; however, these supportive measures do not have an effect on the underlying cause of the disease (McNally et al. 2015). The gene discussed is ACE; the disease is Duchenne muscular dystrophy.